Turnover: 1.4 million EUR (2022)
Country: France
- Subsidiary of the American Sequens group
- Seqens is a global player in pharmaceutical synthesis and specialty ingredients.
- The group offers its customers contract manufacturing services for the pharmaceutical and specialty markets, as well as a broad portfolio of active ingredients, pharmaceutical intermediates and specialty products.
News
Seqens, specialist in pharmaceutical solutions, bidding to acquire the Novartis plant at Les Ulis 31/07/2023
- Novartis is in exclusive negotiations with the Seqens group for the sale of CellForCure and its cell and gene therapy development and production site at Ulis.
- The Ulis site employs 200 people.
- Groupe Seqens specializes in pharmaceutical solutions and specialized ingredients.
France's leading producer of isopropanol, a solvent used as a main component in hydroalcoholic solutions, Seqens hasalcoholic solutions, Seqens redirected part of its business in March 2020 to meet growing needs linked to Covid-19.
"We are providing two production lines at our Bourgoin-Jailleu site with the aim of producing over 30,000 liters of hydroalcoholic gel per day. These large quantities are intended primarily for the hospitathe health sector, but also to the mass retail sector in France", reveals the group."
Financial Data
DUNS: 444465736
Legal Name: SEQENS
Address: 21 CHE DE LA SAUVEGARDE 21 ECULLY PARC - CS 33167, 69130 ECULLY
Number of employees: Entre 100 et 199 salariés (2017)
Capital: 226 890 746 EUR
Financial Data:
Year | Turnover (€) | Net Profit (€) | Fiscal Year End | Fiscal Year Duration |
---|---|---|---|---|
2020 | 15 302 000 EUR | -9 896 000 EUR | 31/12/2020 | 12 |
2019 | 11 483 000 EUR | -16 855 EUR | 31/12/2019 | 12 |
2018 | 8 001 000 EUR | -2 876 000 EUR | 31/12/2018 | 12 |
2017 | 8 297 000 EUR | 16 899 000 EUR | 31/12/2017 | 12 |
2016 | 10 201 000 EUR | -16 183 000 EUR | 31/12/2016 | 12 |
2015 | 10 760 000 EUR | -2 406 000 EUR | 31/12/2015 | 12 |
Studies mentioning this company
Other companies mentioned:
- Seqens
- Urgo Groupe
- MP Hygiène
- Orapi groupe
- Baccide (Coopération Pharmaceutique Française COOPER)
- Sanytol (AC Marca)
- Puressentiel France
- Saraya
- Codexial Dermatologie
- Novartis
- Laboratoires Gilbert (GILBERT Groupe)
- Diepharmex Laboratoires
- Laboratoires Lehning
- Laboratoires Chemineau (Anjac)
- Gifrer Laboratoires
- Mercurochrome (Urgo Groupe)
- Rivadis Laboratoires
- Herbesan (Super diet Laboratiore)